The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil): Factors Related to Smoking Cessation

Carregando...
Imagem de Miniatura
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER
Autores
OLIVEIRA, Thais Lopes de
OLIVEIRA, Raquel Vasconcellos Carvalhaes de
GRIEP, Rosane Harter
MORENO, Arlinda B.
MELO, Enirtes Caetano Prates
TOIVANEN, Susanna
FONSECA, Maria de Jesus Mendes da
Citação
INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, v.29, n.6, p.718-727, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background Smoking cessation is not an easy accomplishment. However, the benefits are several for those who do it, such as cardiovascular risk reduction 1 year after quitting smoking. This study aimed to verify the factors related to smoking cessation in civil servants of The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Methods This study had a longitudinal design using data from a prospective cohort of civil servants (ELSA-Brasil). Our variable of interest was smoking cessation. The relationship between socio-demographic characteristics, job stress, health-related variables, legislation, and smoking cessation was analyzed by Cox proportional hazard models. The analyses were stratified by gender. Second-hand smoke exposure, age, education, excessive alcohol consumption, common mental disorder, and smoking control law were the variables considered in the final model. Results Information of 2020 women and 2429 men was analyzed. Individuals without second-hand smoke exposure, with up to 49 years of age, with higher education, without excessive alcohol consumption, without common mental disorders, and who initiated smoking in 1989 or after the smoking control law had a higher risk of stopping smoking. The risks magnitudes were higher for women. Conclusions Our study reinforces the necessity of alcohol consumption regulation, the relevance of Public Health Policies, and the need for more smoking cessation measures focused on men, on people with mental disorders, alcoholism, and older adults. Also, our results did not show significant risks regarding the psychosocial working environment.
Palavras-chave
Smoking cessation, Occupational stress, Survival analysis, Tobacco
Referências
  1. Ameringer KJ, 2010, NICOTINE TOB RES, V12, P1183, DOI 10.1093/ntr/ntq174
  2. Aquino EML, 2013, REV SAUDE PUBL S2, V47, P10, DOI 10.1590/S0034-8910.2013047003953
  3. Araujo AJ de, 2004, J BRAS PNEUMOL, V30, pS1, DOI [10.1590/S1806-37132004000800002, DOI 10.1590/S1806-37132004000800002]
  4. Barreto SM, 2012, J EPIDEMIOL COMMUN H, V66, P723, DOI 10.1136/jech.2010.122549
  5. Breitling LP, 2010, DRUG ALCOHOL DEPEN, V108, P122, DOI 10.1016/j.drugalcdep.2009.12.005
  6. Carreras G, 2019, PREV MED, V129, DOI 10.1016/j.ypmed.2019.105833
  7. Centers for Disease Control and Prevention, HLTH EFF CIG SMOK
  8. Conroy HE, 2020, COGN BEHAV THERAPY, V49, P361, DOI 10.1080/16506073.2020.1751262
  9. Coppo A, 2017, EUR J PUBLIC HEALTH, V27, P717, DOI 10.1093/eurpub/ckw262
  10. Cruvinel E, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-033959
  11. de Oliveira TL, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7072-y
  12. Drea AJP., 2004, J BRAS PNEUMOL, V30, pS41
  13. Duncan B.B, 2011, REV HCPA, V31, P487
  14. Eng L, 2015, CANCER-AM CANCER SOC, V121, P2655, DOI 10.1002/cncr.29340
  15. Eng L, 2014, J CLIN ONCOL, V32, P564, DOI 10.1200/JCO.2013.50.9695
  16. Faleiro Jéssica Costa, 2017, Cad. Saúde Pública, V33, pe00017916, DOI 10.1590/0102-311x00017916
  17. Fidler J, 2013, ADDICTION, V108, P1680, DOI 10.1111/add.12241
  18. Fond G, 2013, J AFFECT DISORDERS, V149, P418, DOI 10.1016/j.jad.2012.11.066
  19. Fukuoka E, 2008, ACTA MED OKAYAMA, V62, P83
  20. Grambsch Patricia M, 2000, STAT BIOL HEALTH
  21. Griep RH, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1626-4
  22. Griep RH, 2009, INT ARCH OCC ENV HEA, V82, P1163, DOI 10.1007/s00420-009-0460-3
  23. Grotvedt L, 2005, SCAND J PUBLIC HEALT, V33, P72, DOI 10.1080/14034940410028361
  24. Instituto Nacional do Cancer, DAD NUM PREV TAB
  25. Instituto Nacional do Cancer, CONV QUADR CONTR TAB
  26. Instituto Nacional do Cancer, TRAT TAB
  27. Intituto Nacional do Cancer, 2001, AB TRAT FUM CONS
  28. Karasek R, 1998, J Occup Health Psychol, V3, P322, DOI 10.1037/1076-8998.3.4.322
  29. KARASEK RA, 1979, ADMIN SCI QUART, V24, P285, DOI 10.2307/2392498
  30. Kenney BA, 2009, ADDICT BEHAV, V34, P548, DOI 10.1016/j.addbeh.2009.03.020
  31. Kouvonen A, 2005, J EPIDEMIOL COMMUN H, V59, P63, DOI 10.1136/jech.2004.019752
  32. Kouvonen A, 2009, TOB CONTROL, V18, P108, DOI 10.1136/tc.2008.025411
  33. KVIZ FJ, 1995, PREV MED, V24, P297, DOI 10.1006/pmed.1995.1048
  34. Lee W, 2018, ANN WORK EXPOS HEAL, V62, P41, DOI 10.1093/annweh/wxx089
  35. Leem AY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176294
  36. Levy David, 2012, PLoS Med, V9, pe1001336, DOI 10.1371/journal.pmed.1001336
  37. Lynch KL, 2019, NICOTINE TOB RES, V21, P1058, DOI 10.1093/ntr/nty142
  38. Malta Deborah Carvalho, 2015, Rev. bras. epidemiol., V18, P45, DOI 10.1590/1980-5497201500060005
  39. Hokerberg YHM, 2010, INT ARCH OCC ENV HEA, V83, P407, DOI 10.1007/s00420-009-0488-4
  40. Marti J, 2010, INT J ENV RES PUB HE, V7, P2789, DOI 10.3390/ijerph7072789
  41. Ministerio da Saude Secretaria de Vigilancia em Saude Departamento de Analise em Saude e Vigilancia de Doencas nao Transmissiveis, VIG BRAS 2019 VIG FA
  42. Monteiro MG, 2016, EPIDEMIOL SERV SAUDE, V25, P171, DOI 10.5123/S1679-49742016000100017
  43. Moylan S, 2013, BRAIN BEHAV, V3, P302, DOI 10.1002/brb3.137
  44. Ota A, 2010, NICOTINE TOB RES, V12, P287, DOI 10.1093/ntr/ntp212
  45. Patrao AL, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015705
  46. Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802
  47. Pinto MT, 2015, CAD SAUDE PUBLICA, V31, DOI 10.1590/0102-311X00192013
  48. Portes LH, 2018, CIENC SAUDE COLETIVA, V23, P1837, DOI 10.1590/1413-81232018236.05202018
  49. R Core Team, 2020, R LANG ENV STAT COMP
  50. Rugulies R, 2008, INT J BEHAV MED, V15, P34, DOI [10.1007/BF03003072, 10.1080/10705500701783900]
  51. Sanderson DM, 2005, PREV MED, V41, P757, DOI 10.1016/j.ypmed.2005.06.002
  52. Scarinci IC, 2007, HEALTH PROMOT INT, V22, P146, DOI 10.1093/heapro/dam012
  53. Abreu MNS, 2011, REV PANAM SALUD PUBL, V30, P22
  54. un, 2030 AG SUST DEV
  55. Wang RP, 2019, TOB INDUC DIS, V17, DOI 10.18332/tid/114076
  56. Wetter DW, 2005, PREV MED, V40, P452, DOI 10.1016/j.ypmed.2004.07.001
  57. WHO, WHO GLOB REP TRENDS, VSecond
  58. Yasin SM, 2012, OCCUP MED-OXFORD, V62, P174, DOI 10.1093/occmed/kqs005